Screener
United Therapeutics UTHR Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from United Therapeutics’s reported figures.
Based on the most recent quarter.
The source filing: United Therapeutics’s 10-Q, filed May 6, 2026. Open the filing →
- Filed
- May 6, 2026, 6:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001082554-26-000020
FAQ
- What is United Therapeutics's current ratio?
- United Therapeutics (UTHR) reported current ratio of 4.8× in Q1 2026.
- How has United Therapeutics's current ratio changed year-over-year?
- United Therapeutics's current ratio decreased by 12.2% year-over-year, from 5.5× to 4.8×.
- What is the long-term trend for United Therapeutics's current ratio?
- Over 5 years (2020 to 2025), United Therapeutics's current ratio has grown at a -0.3% compound annual growth rate (CAGR), from 6.7× to 6.6×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about United Therapeutics's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude